World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
16648
World Ranking
3391
National Ranking
1569

James E. Talmadge publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James E. Talmadge sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 309 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

James E. Talmadge D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James E. Talmadge sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

James E. Talmadge is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a strong focus on Oncology and Immunology as core subfields. Additional subfields include Public Health, Environmental and Occupational Health, Cancer Research, and Molecular Biology.

The main topics addressed in their work cover a range of areas related to cancer and immune system interactions, including:

  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Pancreatic and Hepatic Oncology Research
  • Cancer Cells and Metastasis
  • Cancer, Lipids, and Metabolism

James E. Talmadge has published extensively in multiple journals. Frequent publication venues include:

  • International Immunopharmacology
  • Cancer and Metastasis Reviews
  • Clinical & Experimental Metastasis
  • Cellular Immunology
  • Advances in experimental medicine and biology

Some of the recent papers authored by or associated with James E. Talmadge are:

  • "Quantity does not equal quality: Scientific principles cannot be sacrificed" (2020, International Immunopharmacology)
  • "Role of myeloid-derived suppressor cells in metastasis" (2021, Cancer and Metastasis Reviews)
  • "Role of myeloid-derived suppressor cells in tumor recurrence" (2023, Cancer and Metastasis Reviews)
  • "Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis" (2021, Cellular Immunology)
  • "Myeloid derived suppressor cells and the release of micro-metastases from dormancy" (2021, Clinical & Experimental Metastasis)

Collaborations are a consistent feature in their research, with frequent co-authors including:

  • Kathryn Cole
  • Zaid Al-Kadhimi
  • Quan P. Ly
  • Jesse L. Cox
  • James C. Padussis

Best Publications

  • History of myeloid-derived suppressor cells

    James E. Talmadge;Dmitry I. Gabrilovich

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Role of NK cells in tumour growth and metastasis in beige mice

    Unknown

  • Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice

    Yasushi Sawanobori;Satoshi Ueha;Makoto Kurachi;Takeshi Shimaoka

  • Inflammatory cell infiltration of tumors: Jekyll or Hyde

    Unknown

  • Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy

    Unknown

  • Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.

    Robert H. Wiltrout;Bonnie J. Mathieson;James E. Talmadge;Craig W. Reynolds

  • Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.

    Sohini Roy;Arup K. Bag;Rakesh K. Singh;James E. Talmadge

  • Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow

    JE Talmadge;E Reed;K Ino;A Kessinger

  • Immunomodulatory and immunotherapeutic properties of recombinant γ-interferon and recombinant tumor necrosis factor in mice

    James E. Talmadge;Henry R. Tribble;Robin W. Pennington;Hamblin Phillips

  • Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice.

    David C. Bibby;James E. Talmadge;Milind K. Dalal;Scott G. Kurz

  • Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion.

    James E. Talmadge;Keith C. Hood;Lori C. Zobel;Laura R. Shafer

  • Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.

    Zhengtang Chen;Michelle L. Varney;Matthew W. Backora;Kenneth H Cowan

  • Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models.

    M P Castelli;P L Black;M Schneider;R Pennington

  • Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.

    J. E. Talmadge;E. C. Reed;A. Kessinger;C. A. Kuszynski

  • Systematic Preclinical Study on the Therapeutic Properties of Recombinant Human Interleukin 2 for the Treatment of Metastatic Disease

    James E. Talmadge;Hamblin Phillips;John Schindler;Henry Tribble

  • Potent Activation of Mouse Macrophages by Recombinant Interferon-γ

    Luigi Varesio;Elisabetta Blasi;Gary B. Thurman;James E. Talmadge

  • Immunomodulatory and Therapeutic Properties of Bestatin in Mice

    James E. Talmadge;Barbara F. Lenz;Robin Pennington;Cedric Long

  • Characterization of a Murine Ovarian Reticulum Cell Sarcoma of Histiocytic Origin

    James E. Talmadge;Marc E. Key;Ian R. Hart

  • Gene Transfer Into Human Bone Marrow Hematopoietic Cells Mediated by Adenovirus Vectors

    T Watanabe;C Kuszynski;K Ino;DG Heimann

  • Interleukin-12 enhances peripheral hematopoiesis in vivo

    John D. Jackson;Yun Yan;Michael J. Brunda;Linda S. Kelsey

  • Immunomodulatory Effects in Mice of Polyinosinic-Polycytidylic Acid Complexed with Poly-l-lysine and Carboxymethylcellulose

    James E. Talmadge;Joanne Adams;Hamblin Phillips;Margaret Collins

  • The pharmaceutics and delivery of therapeutic polypeptides and proteins

    James E. Talmadge

  • GM-CSF-mobilized peripheral blood CD34 + cells differ from steady- state bone marrow CD34 + cells in adhesion molecule expression

    T. Watanabe;Bhavana J Dave;D. G. Heimann;E. Lethaby

  • Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.

    T. Watanabe;Bhavana J Dave;D. G. Heimann;J. D. Jackson

Frequent Co-Authors

Geoffrey M. Thiele
Geoffrey M. Thiele University of Nebraska Medical Center
Julie M. Vose
Julie M. Vose University of Nebraska Medical Center
Devendra K. Agrawal
Devendra K. Agrawal Western University of Health Sciences
Robert H. Wiltrout
Robert H. Wiltrout National Institutes of Health
Rakesh Singh
Rakesh Singh Indian Council of Agricultural Research
Lynell Warren Klassen
Lynell Warren Klassen University of Nebraska Medical Center
Ronald B. Herberman
Ronald B. Herberman University of Pittsburgh
Concetta C. DiRusso
Concetta C. DiRusso University of Nebraska–Lincoln
Paul N. Black
Paul N. Black University of Nebraska–Lincoln
Michael A. Hollingsworth
Michael A. Hollingsworth University of Nebraska Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often connects students to broader healthcare fields, especially nursing and advanced practice roles. For those interested in mental health and clinical care, exploring the easiest NP programs to get into can be a practical starting point. These programs provide a manageable entry path while offering essential nursing education.

Specializing further, the demand for Psychiatric-Mental Health Nurse Practitioners is growing rapidly. Accessing the best PMHNP programs online ensures excellent clinical placement opportunities, which are crucial for hands-on experience and career readiness in mental health nursing.

Cost is often a major consideration. Thankfully, there are also affordable PMHNP programs that combine quality education with financial accessibility. These programs make advanced nursing degrees more attainable without compromising training quality.

Career outcomes for those with advanced nursing degrees are promising. For example, a doctorate in nursing salary reflects strong earning potential across the USA, reflecting the high demand for expert care providers. Immunology graduates venturing into nursing or nurse practitioner roles will find a range of supportive educational pathways and rewarding career options.

Best Scientists Citing James E. Talmadge

Trending Scientists